Understanding the relationship between prevalence of microfilariae and antigenaemia using a model of lymphatic filariasis infection

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 110, Issue 2, 2016, Pages 118-124

  Irvine, Michael A ^a   Njenga, Sammy M ^b   Gunawardena, Shamini ^c   Wamae, Claire Njeri ^d   Cano, Jorge ^c   Brooker, Simon J ^c   Deirdre Hollingsworth, T ^a,e  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^c MOUNT KENYA UNIVERSITY   (Kenya)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Antigenaemia; Elimination programme; Lymphatic filariasis; Microfilaraemia; Prevalence surveys

Indexed keywords

ALBENDAZOLE; DIETHYLCARBAMAZINE; ANTIFILARIAL AGENT; PARASITE ANTIGEN;

ANTIGENAEMIA; ARTICLE; HELMINTHIASIS; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOCHROMATOGRAPHIC TEST; LYMPHATIC FILARIASIS; MICROFILARIA (NEMATODE LARVA); MICROFILARIASIS; PREVALENCE; ANIMAL; BLOOD; ELEPHANTIASIS, FILARIAL; HEALTH SURVEY; HETEROZYGOTE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; PARASITOLOGY; THEORETICAL MODEL; WUCHERERIA BANCROFTI;

ANIMALS; ANTIGENS, HELMINTH; CARRIER STATE; ELEPHANTIASIS, FILARIAL; FILARICIDES; HUMANS; IMMUNOCHROMATOGRAPHY; MICROFILARIAE; MODELS, THEORETICAL; PREVALENCE; PUBLIC HEALTH SURVEILLANCE; WUCHERERIA BANCROFTI;

EID: 84961658128     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trv096     Document Type: Article

References (29)

1. Rebollo MP, Bockarie MJ. Toward the elimination of lymphatic filariasis by 2020: treatment update and impact assessment for the endgame. Exp Rev Anti Infect Ther 2013;11:723-31.
2. Koudou B. Elimination of lymphatic filariasis: The endgame and challenges for meeting the 2020 target. Int J Infect Dis 2014;21:42.
3. Rebollo MP, Bockarie MJ. Shrinking the lymphatic filariasis map: update on diagnostic tools for mapping and transmission monitoring. Parasitology 2014;141:1912-7.
4. Chandrasena T, Premaratna R, Abeyewickrema W, de Silva N. Evaluation of the ICT whole-blood antigen card test to detect infection due to Wuchereria bancrofti in Sri Lanka. Trans R Soc Trop Med Hyg 2002;96:60-3.
5. Weil GJ, Ramzy RM. Diagnostic tools for filariasis elimination programs. Trends Parasitol 2007;23:78-82.
6. Weil G, Lammie P, Weiss N. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 1997;13:401-4.
7. Grenfell B, Michael E, Denham D. A model for the dynamics of human lymphatic filariasis. Parasitol Today 1991;7:318-23.
8. Taylor MJ, Hoerauf A, Bockarie M. Lymphatic filariasis and onchocerciasis. Lancet 2010;376:1175-85.
9. Figueredo-Silva J, Jungmann P, Norões J et al. Histological evidence for adulticidal effect of low doses of diethylcarbamazine in bancroftian filariasis. Trans R Soc Trop Med Hyg 1996;90:192-4.
10. Cano J, Moraga P, Nikolay B et al. An investigation of the disparity in estimates of microfilaraemia and antigenaemia in lymphatic filariasis surveys. Trans R Soc Trop Med Hyg 2015;109:529-31.
11. Anderson RM, May RM, Anderson B. Infectious Diseases of Humans:Dynamics and Control. Wiley Online Library; 1992.
12. Michael E, Malecela-Lazaro MN, Simonsen PE et al. Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis 2004;4:223-34.
13. May RM. Togetherness among schistosomes: its effects on the dynamics of the infection. Math Biosci 1977;35:301-43.
14. NguyenN, Plichart C, Esterre P. Assessment of immunochromatographic test for rapid lymphatic filariasis diagnosis. Parasite 1999;6:355-8.
15. Njenga SM,Wamae CN, Njomo DWet al. Impact of two rounds of mass treatment with diethylcarbamazine plus albendazole on Wuchereria bancrofti infection and the sensitivity of immunochromatographic test in Malindi, Kenya. Trans R Soc Trop Med Hyg 2008;102:1017-24.
16. Gunawardena S, Ismail M, Bradley M, Karunaweera N. Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka. Trans R Soc Trop Med Hyg 2007;101:445-53.
17. Hairston NG, de Meillon B. On the inefficiency of transmission of Wuchereria bancrofti from mosquito to human host. Bull World Health Organ 1968;385.
18. Das P, Manoharan A, Subramanian S et al. Bancroftian filariasis in Pondicherry, south India-epidemiological impact of recovery of the vector population. Epidemiol Infect 1992;108:483-93.
19. Patil A, Huard D, Fonnesbeck CJ. PyMC: Bayesian stochastic modelling in Python. J Stat Softw 2010;35:1.
20. Subramanian S, Stolk W, Ramaiah K et al. The dynamics of Wuchereria bancrofti infection: a model-based analysis of longitudinal data from Pondicherry, India. Parasitology 2004;128:467-82.
21. Burkina Faso MoH. Programme to Eliminate Lymphatic Filariasis. Country Report WHO; BFA0020_LF2010. Ouagadougou: Burkina Faso Ministry of Health; 2010.
22. Ramzy RM, El Setouhy M, Helmy H et al. Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006;367:992-9.
23. Nigeria MoH. Programme to Eliminate Lymphatic Filariasis. Country Report WHO; NGA0004_LF2004. Abuja: Nigeria Ministry of Health; 2004.
24. Fraser M, Taleo G, Taleo F et al. Evaluation of the program to eliminate lymphatic filariasis in Vanuatu following two years of mass drug administration implementation: results and methodologic approach. Am J Trop Med Hyg 2005;73:753-8.
25. Bockarie MJ, Tavul L, Ibam I et al. Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea. Am J Trop Med Hyg 2007;76:62-6.
26. Olsen A. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans R Soc Trop Med Hyg 2007;101:747-58.
27. Gass K, Beau de Rochars M, Boakye D et al. A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl Trop Dis 2012;6:e1479.
28. Mladonicky JM, King JD, Liang JL et al. Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa. Am J Trop Med Hyg 2009;80:769-73.
29. Rao RU, Nagodavithana KC, Samarasekera SD et al. A comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administration. PLoS Negl Trop Dis 2014;8:e3281. Correction in: PLoS Negl Trop Dis 2014;8:e3428.